SCHEMBL4334347

SCHEMBL4334347

CCOC(=O)C(Cc1cccc(N)c1)OC(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.40
ADRB2 P07550 5/20 0.38
MMP8 P22894 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
MAPK1 P28482 2/20 0.38
TSHR P16473 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ALDH1A1 P00352 3/20 0.38
TP53 P04637 2/20 0.38
CYP3A4 P08684 1/20 0.36
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
HSD17B10 Q99714 1/20 0.36
LMNA P02545 1/20 0.36
ADRB1 P08588 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13810212 0.86 LOXL2 (0.41) SMN1; SMN2MMP8L3MBTL1MAPK1TSHR
SCHEMBL4081032 0.86 PPARG (0.44) SMN1; SMN2MMP8
Hydrochloric Acid SCHEMBL4332232 0.85 LOXL2 (0.40) SMN1; SMN2MMP8L3MBTL1MAPK1TSHR
SCHEMBL4332258 0.85 GRIA2 (0.42) MMP8L3MBTL1MAPK1TSHRTDP1
SCHEMBL4329899 0.85 MMP8 (0.39) SMN1; SMN2MMP8L3MBTL1MAPK1TSHR
SCHEMBL4332255 0.85 GRIA2 (0.42) MMP8L3MBTL1MAPK1TSHRTDP1
SCHEMBL13810945 0.84 L3MBTL1 (0.44) MMP8L3MBTL1MAPK1TSHRTDP1
SCHEMBL13819361 0.84 CYP4F2 (0.41) MMP8L3MBTL1MAPK1TSHRTDP1
SCHEMBL4332256 0.84 MMP8 (0.38) SMN1; SMN2MMP8L3MBTL1MAPK1TSHR
SCHEMBL1857286 0.83 LMNA (0.46) SMN1; SMN2MMP8TSHRALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100522944-C Carboxylic acid derivatives and salts thereof EISAI CO LTD (JP) 2009-08-05 CN disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
CN-1503774-A Carboxylic acid derivatives and salts thereof ������������ʽ���� 2004-06-09 CN disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 SMN1; SMN2 3054/4885ADRB2 547/4885MMP8 2034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.